71 related articles for article (PubMed ID: 15033457)
21. Effect of curcumin on multidrug resistance in resistant human gastric carcinoma cell line SGC7901/VCR.
Tang XQ; Bi H; Feng JQ; Cao JG
Acta Pharmacol Sin; 2005 Aug; 26(8):1009-16. PubMed ID: 16038636
[TBL] [Abstract][Full Text] [Related]
22. P-glycoprotein (MDR1) functional activity in human alveolar epithelial cell monolayers.
Endter S; Becker U; Daum N; Huwer H; Lehr CM; Gumbleton M; Ehrhardt C
Cell Tissue Res; 2007 Apr; 328(1):77-84. PubMed ID: 17165089
[TBL] [Abstract][Full Text] [Related]
23. Human pharmaceuticals modulate P-gp1 (ABCB1) transport activity in the fish cell line PLHC-1.
Caminada D; Zaja R; Smital T; Fent K
Aquat Toxicol; 2008 Nov; 90(3):214-22. PubMed ID: 18950875
[TBL] [Abstract][Full Text] [Related]
24. Reversal of p-glycoprotein-mediated multidrug resistance by macrocyclic bisbibenzyl derivatives in adriamycin-resistant human myelogenous leukemia (K562/A02) cells.
Li X; Sun B; Zhu CJ; Yuan HQ; Shi YQ; Gao J; Li SJ; Lou HX
Toxicol In Vitro; 2009 Feb; 23(1):29-36. PubMed ID: 18938236
[TBL] [Abstract][Full Text] [Related]
25. Effect of E6, a novel calmodulin inhibitor, on activity of P-glycoprotein in purified primary cultured rat brain microvessel endothelial cells.
Zhu HJ; Liu GQ
Acta Pharmacol Sin; 2003 Nov; 24(11):1143-9. PubMed ID: 14627500
[TBL] [Abstract][Full Text] [Related]
26. The effect of ABCB1 polymorphism on the pharmacokinetics of saquinavir alone and in combination with ritonavir.
la Porte CJ; Li Y; Béïque L; Foster BC; Chauhan B; Garber GE; Cameron DW; van Heeswijk RP
Clin Pharmacol Ther; 2007 Oct; 82(4):389-95. PubMed ID: 17361121
[TBL] [Abstract][Full Text] [Related]
27. Effect of triterpenoids isolated from the floral spikes of Betula platyphylla var. japonica on P-glycoprotein function.
Sekiya M; Kashiwada Y; Nabekura T; Kitagawa S; Yamagishi T; Yokozawa T; Ichiyanagi T; Ikeshiro Y; Takaishi Y
Planta Med; 2007 Dec; 73(15):1558-62. PubMed ID: 18058609
[TBL] [Abstract][Full Text] [Related]
28. JC-1, a sensitive probe for a simultaneous detection of P-glycoprotein activity and apoptosis in leukemic cells.
Chaoui D; Faussat AM; Majdak P; Tang R; Perrot JY; Pasco S; Klein C; Marie JP; Legrand O
Cytometry B Clin Cytom; 2006 May; 70(3):189-96. PubMed ID: 16568474
[TBL] [Abstract][Full Text] [Related]
29. Comparison of the inhibitory activity of anti-HIV drugs on P-glycoprotein.
Storch CH; Theile D; Lindenmaier H; Haefeli WE; Weiss J
Biochem Pharmacol; 2007 May; 73(10):1573-81. PubMed ID: 17328866
[TBL] [Abstract][Full Text] [Related]
30. Functional correlation of P-glycoprotein expression and genotype with expression of the human immunodeficiency virus type 1 coreceptor CXCR4.
Owen A; Chandler B; Bray PG; Ward SA; Hart CA; Back DJ; Khoo SH
J Virol; 2004 Nov; 78(21):12022-9. PubMed ID: 15479841
[TBL] [Abstract][Full Text] [Related]
31. Expression of pregnane-X-receptor transcript in peripheral blood mononuclear cells and correlation with MDR1 mRNA.
Owen A; Chandler B; Back DJ; Khoo SH
Antivir Ther; 2004 Oct; 9(5):819-21. PubMed ID: 15535420
[TBL] [Abstract][Full Text] [Related]
32. Curcuma drugs and curcumin regulate the expression and function of P-gp in Caco-2 cells in completely opposite ways.
Hou XL; Takahashi K; Tanaka K; Tougou K; Qiu F; Komatsu K; Takahashi K; Azuma J
Int J Pharm; 2008 Jun; 358(1-2):224-9. PubMed ID: 18439772
[TBL] [Abstract][Full Text] [Related]
33. P-glycoprotein in intestines, liver, kidney and lymphocytes in horse.
Tydén E; Tallkvist J; Tjälve H; Larsson P
J Vet Pharmacol Ther; 2009 Apr; 32(2):167-76. PubMed ID: 19290947
[TBL] [Abstract][Full Text] [Related]
34. Differential drug susceptibility of intracellular and extracellular tuberculosis, and the impact of P-glycoprotein.
Hartkoorn RC; Chandler B; Owen A; Ward SA; Bertel Squire S; Back DJ; Khoo SH
Tuberculosis (Edinb); 2007 May; 87(3):248-55. PubMed ID: 17258938
[TBL] [Abstract][Full Text] [Related]
35. Involvement of P-glycoprotein in the release of cytokines from peripheral blood mononuclear cells treated with methotrexate and dexamethasone.
Pawlik A; Baśkiewicz-Masiuk M; Machaliński B; Safranow K; Gawrońska-Szklarz B
J Pharm Pharmacol; 2005 Nov; 57(11):1421-5. PubMed ID: 16259774
[TBL] [Abstract][Full Text] [Related]
36. Substituted tetrahydroisoquinoline compound B3 inhibited P-glycoprotein-mediated multidrug resistance in-vitro and in-vivo.
Fang W; Li Y; Cai Y; Kang K; Yan F; Liu G; Huang W
J Pharm Pharmacol; 2007 Dec; 59(12):1649-55. PubMed ID: 18053326
[TBL] [Abstract][Full Text] [Related]
37. P-Glycoprotein is localized in intermediate-density membrane microdomains distinct from classical lipid rafts and caveolar domains.
Radeva G; Perabo J; Sharom FJ
FEBS J; 2005 Oct; 272(19):4924-37. PubMed ID: 16176266
[TBL] [Abstract][Full Text] [Related]
38. Rapid assessment of p-glycoprotein-drug interactions at the blood-brain barrier.
Bubik M; Ott M; Mahringer A; Fricker G
Anal Biochem; 2006 Nov; 358(1):51-8. PubMed ID: 16942742
[TBL] [Abstract][Full Text] [Related]
39. Detection of P-glycoprotein efflux activity on peripheral blood lymphocyte subsets from HIV+ patients.
Lucia MB; Rutella S; Rumi C; Ventura G; Caldarola G; Cauda R
Eur J Histochem; 1997; 41 Suppl 2():195-6. PubMed ID: 9859845
[No Abstract] [Full Text] [Related]
40. Synthesis and characterization of macromolecular rhodamine tethers and their interactions with P-glycoprotein.
Crawford L; Putnam D
Bioconjug Chem; 2014 Aug; 25(8):1462-9. PubMed ID: 25050613
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
